Aazami and Salehi must be commended for speculating that systolic coronary perfusion disturbance can be a factor in the occurrence of postoperative atrial fibrillation (AF) as a unique pathophysiological pathway by inducing functional atrial ischemia [1]. However, as their proposed pathophysiological mechanism still needs validation therefore at present the issue of whether or not we are missing a common pathophysiological pathway is irrelevant.
Aazami and Salehi must be commended for speculating that systolic coronary perfusion disturbance can be a factor in the occurrence of postoperative atrial fibrillation (AF) as a unique pathophysiological pathway by inducing functional atrial ischemia [1] . However, as their proposed pathophysiological mechanism still needs validation therefore at present the issue of whether or not we are missing a common pathophysiological pathway is irrelevant.
They have also pointed out that unaccounted for confounding factors in randomised controlled trials (RCTs) such as more deliberate revascularization in on-pump coronary artery bypass grafting and nature of grafts may influence the incidence of postoperative AF. I will agree with Aazami and Salehi in this regard. Unfortunately confounding is perhaps the most significant dilemma even in well designed and analysed surgical RCTs. Despite randomisation being the ultimate method for arriving at comparable groups [2] , because it indirectly matches for all prognostic variables, recognized and unrecognised, equipoise is impossible to achieve in surgical RCTs due to several hidden confounding factors. Hence, unless more sophisticated statistical methods and randomisation techniques are devised, bias in surgical RCTs cannot be completely eliminated although it can be minimized.
Finally as for their view that efficient off-pump total arterial revascularization appears unconceivable at present owing to concerns about the increased risk of competitive flow with early arterial graft failure I will take this opportunity to highlight that plenty of evidence from RCTs as well as retrospective studies is available to validate that total arterial myocardial revascularization can be safely performed as an off-pump procedure, even in the treatment of multiple-vessel coronary disease [3, 4] . In fact, off-pump composite total arterial grafting has become a routine these days with concerns about competitive flow, the mechanism of which is more complex than that in the individual graft, not yet proven [5] . It is important to remember that competitive flow is not only caused by the relation between the graft and its target coronary branch where competitive flow occurs, but also by the interactions of all anastomosed branches within the composite graft, the phasic delay between the in situ grafts, and the whole graft arrangement in the patient [5] . Therefore, prevention of competitive flow and graft occlusion depends entirely on adequate surgical strategy and manoeuvre rather than whether the revascularization is performed on-pump or off-pump.
We read with great interest the article by Takeuchi and colleagues on the effects of papaverine hydrochloride, isosorbide dinitrate (ISDN) and phosphodiesterase III inhibitor (PDE III-I) on the free blood flow in human internal thoracic artery (ITA) conduits [1] . The authors found that PDE III-I was most effective for increasing the free blood flow of the ITA graft and that papaverine had no effect at all.
The free ITA blood flow increased only from around 37 ml/min before medical treatment to 40 ml/min after papaverine, 48 ml/min after ISDN and 57 ml/min after PDE III-I.
These results are in contrast to previous work in this area [2, 3] . In a similar study, we compared the free flow between pedicled and skeletonized ITA grafts before and after intraluminal injection of papaverine [3] . Although we found similar baseline free flows in the ITA conduits (skeletonized: 51 ml/min and pedicled: 69 ml/min), the flow significantly increased after treatment with papaverine (skeletonized: 197 ml/min and pedicled: 147 ml/min).
Why was the ITA free flow post-pharmacological treatment in our study over three folds higher than that achieved in Takeuchi's work? Takeuchi and colleagues used an interval of only 1 min after vasodilator injection to measure graft flow, whereas we assessed graft flow 15 min after papaverine injection. Is a 1 min time interval after treatment with papaverine too short to assess for maximum vasodilation of the ITA? In addition, the period of time which was used to calculate free blood flow per minute was only 10 s in Takeuchi's study compared to 20 s in our investigation. This may have some statistical implications.
In both studies papaverine was injected intraluminally. However, the concentration of papaverine used in our study was only 2.5 mg/ml, whereas Takeuchi et al. used concentrations of 4 mg/ml. It could be that the higher concentrations induced endothelial damage of the ITA which then reduced free flow [4] .
There is no mention in the methodology of the technique of ITA preparation. There is a significant difference in flow rates between pedicled and skeletonized grafts after injection of papaverine (see earlier). It would therefore be interesting to see if PDE III-I has a significantly different effect in skeletonized compared to pedicled ITAs.
Finally, low flow rates in ITA grafts have important clinical implications, especially if they are to be used for instance as 'T'-grafts in complex arterial revascularizations. In this type of configuration, total coronary bypass flow is dependent on the flow in the proximal ITA. If this is low, either as a result of poor harvesting technique or suboptimal treatment with vasodilator, hypoperfusion syndrome with global ischemia can ensue [5] .
We appreciate the interest that Dr Motallebzadeh and Dr Wendler have expressed about our article on the reactivity of the human internal thoracic artery to vasodilators in coronary artery bypass grafting (CABG) [1] . First, we used pedicled internal thoracic artery (ITA) graft during CABG.
Why did the ITA free flow in our study differ from that of Dr Wendler's? I agree with the indication of Dr Wendler and feel that their result is wonderful [2] . But I think that the indication does not show the whole picture. There may also be influence of the physique. The stump of the left ITA where we measured free flow was distal to the planned anastomotic site to the left anterior descending artery (LAD). We also measured the flow of the left ITA using the flow meter after anastomosis of the LAD. There were no large difference between the preanastomotic free flow and postanastomotic ITA flow.
We know that maximal vasodilation to papaverine hydrochloride requires at least 10 min of exposure [3] and that maximal mean response to PDEIII inhibitor requires at least 15 min [4] . However, in the PDEIII inhibitor there was a significant increase in left ITA free flow even 1 min after injection. We measure the flow 1 min after vasodilator injection because we want to eliminate influence of change of circulatory dynamic state, circulation temperature, anesthetic drug and so on. Recently, that off-pump CABG (OPCAB) is increasing in number and vasodilator with faster reactivity is becoming the current trend.
Moreover, I think that PDEIII inhibitor is useful because it has an inotropic action which is not found in papaverine hydrochloride [5] .
